Free Trial

CME Group Inc. (NASDAQ:CME) Shares Bought by Dakota Wealth Management

CME Group logo with Finance background

Dakota Wealth Management increased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 126.4% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 6,017 shares of the financial services provider's stock after purchasing an additional 3,359 shares during the period. Dakota Wealth Management's holdings in CME Group were worth $1,596,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in CME. Vanguard Group Inc. boosted its stake in shares of CME Group by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 34,243,090 shares of the financial services provider's stock worth $7,952,273,000 after buying an additional 326,623 shares during the period. Geode Capital Management LLC boosted its stake in shares of CME Group by 1.3% during the fourth quarter. Geode Capital Management LLC now owns 8,389,442 shares of the financial services provider's stock worth $1,946,717,000 after buying an additional 104,697 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of CME Group by 89.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after buying an additional 3,921,278 shares during the period. Norges Bank acquired a new stake in shares of CME Group during the fourth quarter worth about $1,107,389,000. Finally, FIL Ltd raised its holdings in CME Group by 1.5% during the fourth quarter. FIL Ltd now owns 4,081,391 shares of the financial services provider's stock worth $947,821,000 after purchasing an additional 61,908 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CME has been the subject of several analyst reports. Bank of America increased their price target on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Erste Group Bank cut shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. JPMorgan Chase & Co. cut their price target on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Barclays increased their price target on shares of CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a report on Thursday, July 10th. Finally, Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a report on Sunday. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $261.80.

Read Our Latest Analysis on CME

Insider Transactions at CME Group

In other CME Group news, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction that occurred on Monday, May 19th. The shares were sold at an average price of $277.88, for a total value of $294,552.80. Following the completion of the sale, the director directly owned 3,108 shares of the company's stock, valued at approximately $863,651.04. The trade was a 25.43% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 390 shares of CME Group stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total transaction of $108,225.00. Following the completion of the sale, the general counsel directly owned 6,708 shares of the company's stock, valued at $1,861,470. The trade was a 5.49% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock worth $3,680,610 in the last three months. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

Shares of CME stock traded up $1.55 during trading hours on Thursday, hitting $279.08. The company's stock had a trading volume of 1,037,045 shares, compared to its average volume of 2,173,683. The business has a fifty day moving average of $276.17 and a 200-day moving average of $260.04. The stock has a market cap of $100.57 billion, a price-to-earnings ratio of 28.08, a P/E/G ratio of 4.80 and a beta of 0.44. CME Group Inc. has a twelve month low of $193.25 and a twelve month high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.61 by $0.19. The business had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The company's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the business earned $2.50 earnings per share. As a group, equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a yield of 1.79%. CME Group's payout ratio is currently 50.30%.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines